CNBC   |  June 17, 2013

An Anti-Competitive Decision?

The Supreme Court ruled today that the FTC can keep challenging "pay to delay" deals between pharmaceutical companies and generic drugmakers. CNBC Contributor Keith Boykin; Heather Higgins, Independent Women's Voice; and Doug Holtz-Eakin, American Acti...

Share This:

Sorry, we do not have a transcript available for this video at this time.